Related Experiment Video
Updated: Jan 19, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
[Conjunctival malignancies]
Claudia Auw-Hädrich1, Thomas Reinhard2
1Klinik für Augenheilkunde Freiburg, Killianstr. 5, 79106, Freiburg, Deutschland. claudia.auw-haedrich@uniklinik-freiburg.de.
Abstract:
Conjunctival malignancies are rare. However, some of these tumors are among the most aggressive malignancies in ophthalmology and require radical forms of therapy that may lead to blindness or loss of the ipsilateral eye and tumor-associated death. The most relevant primary conjunctival malignancies for oncologists are squamous cell carcinoma, malignant melanoma and malignant lymphoma. Surgical therapy is the primary treatment for squamous cell carcinoma and malignant melanoma. An adjuvant therapy in the form of topical chemotherapy or radiation is necessary in most cases. The isolated malignant lymphoma of the conjunctiva is biopsied excisionally if possible. However, if an incisional biopsy was unavoidable, additional irradiation should be performed; malignant lymphoma generally responds very well to relatively low irradiation doses with a good prognosis quad vitam. More aggressive forms, such as diffuse large cell B‑cell lymphoma or mantle cell lymphoma, must also be treated systemically at an early stage.
Insights
Conjunctival malignancies, though rare, are aggressive eye cancers. Treatment varies by type, including surgery, topical chemotherapy, or radiation, with lymphoma often responding well to irradiation.
Area of Science:
- Ophthalmology
- Oncology
Background:
- Conjunctival malignancies are rare but can be aggressive, potentially leading to blindness, eye loss, or death.
- Key primary conjunctival tumors include squamous cell carcinoma, malignant melanoma, and malignant lymphoma.
Purpose of the Study:
- To outline the primary conjunctival malignancies and their treatment strategies.
- To emphasize the importance of tailored therapeutic approaches for different conjunctival tumors.
Main Methods:
- Review of treatment modalities for squamous cell carcinoma and malignant melanoma, focusing on surgical therapy and adjuvant treatments.
- Discussion of diagnostic and therapeutic approaches for conjunctival malignant lymphoma, including biopsy and radiation therapy.
Main Results:
- Squamous cell carcinoma and malignant melanoma are primarily treated with surgery, often requiring adjuvant topical chemotherapy or radiation.
- Conjunctival malignant lymphoma typically responds well to low-dose irradiation, offering a good prognosis, but aggressive subtypes require systemic treatment.
Conclusions:
- Effective management of conjunctival malignancies necessitates accurate diagnosis and tailored treatment strategies.
- Early intervention and appropriate therapy, including surgery, radiation, and systemic treatments, are crucial for improving outcomes in patients with these rare eye cancers.
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Accessory Structures of the Eye

